Serum lipids and risk of obesity-related cancers in postmenopausal women

Geoffrey C. Kabat, Mimi Kim, Rowan T. Chlebowski, Mara Z. Vitolins, Sylvia Wassertheil-Smoller, Thomas E. Rohan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Obesity, which is commonly accompanied by dyslipidemia, is associated with an increased risk of certain cancers. However, the association of serum lipids with specific obesity-related cancers is unclear. Methods: We examined the association of baseline lipids (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) with risk of developing seven obesity-related cancers in a subcohort of 24,208 participants in the Women’s Health Initiative. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for quartiles of lipids with cancers of the breast, colorectum, pancreas, endometrium, ovary, and kidney, and multiple myeloma. Results: Total cholesterol and LDL-C showed no association with these outcomes. HDL-C was inversely associated, and triglycerides were positively associated, with several cancers. However, after adjustment for other lipids or insulin, consideration of preclinical disease, and exclusion of women taking statins, most associations were attenuated and no longer significant. Only the inverse association of HDL-C with pancreatic cancer (HR for highest vs. lowest quartile 0.52, 95% CI 0.32–0.85, p for trend 0.007) and the positive association of triglycerides with kidney cancer (HR for highest vs. lowest quartile 3.21, 95% CI 1.63–6.33, p for trend = 0.0001) remained significant. However, the inverse association of HDL-C with pancreatic cancer was no longer significant when women who lost substantial weight before diagnosis were excluded. Conclusions: Our results suggest that when possible sources of confounding and bias are taken into account there are few robust associations of lipids with obesity-related cancers.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalCancer Causes and Control
DOIs
StateAccepted/In press - Dec 2 2017

Fingerprint

Obesity
HDL Cholesterol
Lipids
Serum
Confidence Intervals
Neoplasms
Pancreatic Neoplasms
LDL Cholesterol
Triglycerides
Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Kidney Neoplasms
Women's Health
Dyslipidemias
Endometrium
Multiple Myeloma
Proportional Hazards Models
Pancreas
Ovary
Insulin

Keywords

  • Cancer
  • High-density lipoprotein cholesterol
  • Lipids
  • Postmenopausal women
  • Triglycerides

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Serum lipids and risk of obesity-related cancers in postmenopausal women. / Kabat, Geoffrey C.; Kim, Mimi; Chlebowski, Rowan T.; Vitolins, Mara Z.; Wassertheil-Smoller, Sylvia; Rohan, Thomas E.

In: Cancer Causes and Control, 02.12.2017, p. 1-12.

Research output: Contribution to journalArticle

Kabat, Geoffrey C. ; Kim, Mimi ; Chlebowski, Rowan T. ; Vitolins, Mara Z. ; Wassertheil-Smoller, Sylvia ; Rohan, Thomas E. / Serum lipids and risk of obesity-related cancers in postmenopausal women. In: Cancer Causes and Control. 2017 ; pp. 1-12.
@article{fb9d50b596724ad292bc7bb9be031d2a,
title = "Serum lipids and risk of obesity-related cancers in postmenopausal women",
abstract = "Purpose: Obesity, which is commonly accompanied by dyslipidemia, is associated with an increased risk of certain cancers. However, the association of serum lipids with specific obesity-related cancers is unclear. Methods: We examined the association of baseline lipids (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) with risk of developing seven obesity-related cancers in a subcohort of 24,208 participants in the Women’s Health Initiative. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95{\%} confidence intervals (CIs) for quartiles of lipids with cancers of the breast, colorectum, pancreas, endometrium, ovary, and kidney, and multiple myeloma. Results: Total cholesterol and LDL-C showed no association with these outcomes. HDL-C was inversely associated, and triglycerides were positively associated, with several cancers. However, after adjustment for other lipids or insulin, consideration of preclinical disease, and exclusion of women taking statins, most associations were attenuated and no longer significant. Only the inverse association of HDL-C with pancreatic cancer (HR for highest vs. lowest quartile 0.52, 95{\%} CI 0.32–0.85, p for trend 0.007) and the positive association of triglycerides with kidney cancer (HR for highest vs. lowest quartile 3.21, 95{\%} CI 1.63–6.33, p for trend = 0.0001) remained significant. However, the inverse association of HDL-C with pancreatic cancer was no longer significant when women who lost substantial weight before diagnosis were excluded. Conclusions: Our results suggest that when possible sources of confounding and bias are taken into account there are few robust associations of lipids with obesity-related cancers.",
keywords = "Cancer, High-density lipoprotein cholesterol, Lipids, Postmenopausal women, Triglycerides",
author = "Kabat, {Geoffrey C.} and Mimi Kim and Chlebowski, {Rowan T.} and Vitolins, {Mara Z.} and Sylvia Wassertheil-Smoller and Rohan, {Thomas E.}",
year = "2017",
month = "12",
day = "2",
doi = "10.1007/s10552-017-0991-y",
language = "English (US)",
pages = "1--12",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Serum lipids and risk of obesity-related cancers in postmenopausal women

AU - Kabat, Geoffrey C.

AU - Kim, Mimi

AU - Chlebowski, Rowan T.

AU - Vitolins, Mara Z.

AU - Wassertheil-Smoller, Sylvia

AU - Rohan, Thomas E.

PY - 2017/12/2

Y1 - 2017/12/2

N2 - Purpose: Obesity, which is commonly accompanied by dyslipidemia, is associated with an increased risk of certain cancers. However, the association of serum lipids with specific obesity-related cancers is unclear. Methods: We examined the association of baseline lipids (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) with risk of developing seven obesity-related cancers in a subcohort of 24,208 participants in the Women’s Health Initiative. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for quartiles of lipids with cancers of the breast, colorectum, pancreas, endometrium, ovary, and kidney, and multiple myeloma. Results: Total cholesterol and LDL-C showed no association with these outcomes. HDL-C was inversely associated, and triglycerides were positively associated, with several cancers. However, after adjustment for other lipids or insulin, consideration of preclinical disease, and exclusion of women taking statins, most associations were attenuated and no longer significant. Only the inverse association of HDL-C with pancreatic cancer (HR for highest vs. lowest quartile 0.52, 95% CI 0.32–0.85, p for trend 0.007) and the positive association of triglycerides with kidney cancer (HR for highest vs. lowest quartile 3.21, 95% CI 1.63–6.33, p for trend = 0.0001) remained significant. However, the inverse association of HDL-C with pancreatic cancer was no longer significant when women who lost substantial weight before diagnosis were excluded. Conclusions: Our results suggest that when possible sources of confounding and bias are taken into account there are few robust associations of lipids with obesity-related cancers.

AB - Purpose: Obesity, which is commonly accompanied by dyslipidemia, is associated with an increased risk of certain cancers. However, the association of serum lipids with specific obesity-related cancers is unclear. Methods: We examined the association of baseline lipids (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides) with risk of developing seven obesity-related cancers in a subcohort of 24,208 participants in the Women’s Health Initiative. We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for quartiles of lipids with cancers of the breast, colorectum, pancreas, endometrium, ovary, and kidney, and multiple myeloma. Results: Total cholesterol and LDL-C showed no association with these outcomes. HDL-C was inversely associated, and triglycerides were positively associated, with several cancers. However, after adjustment for other lipids or insulin, consideration of preclinical disease, and exclusion of women taking statins, most associations were attenuated and no longer significant. Only the inverse association of HDL-C with pancreatic cancer (HR for highest vs. lowest quartile 0.52, 95% CI 0.32–0.85, p for trend 0.007) and the positive association of triglycerides with kidney cancer (HR for highest vs. lowest quartile 3.21, 95% CI 1.63–6.33, p for trend = 0.0001) remained significant. However, the inverse association of HDL-C with pancreatic cancer was no longer significant when women who lost substantial weight before diagnosis were excluded. Conclusions: Our results suggest that when possible sources of confounding and bias are taken into account there are few robust associations of lipids with obesity-related cancers.

KW - Cancer

KW - High-density lipoprotein cholesterol

KW - Lipids

KW - Postmenopausal women

KW - Triglycerides

UR - http://www.scopus.com/inward/record.url?scp=85035795121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035795121&partnerID=8YFLogxK

U2 - 10.1007/s10552-017-0991-y

DO - 10.1007/s10552-017-0991-y

M3 - Article

C2 - 29197994

AN - SCOPUS:85035795121

SP - 1

EP - 12

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

ER -